Trade Summary

5 days ago, Dambkowski Carl, serving as Dir at Oruka Therapeutics, Inc. (ORKA), sold 35,000 shares at $70.13 per share, for a total transaction value of $2,454,382.15. Following this transaction, Dambkowski Carl now holds 38,743 shares of ORKA.

This sale represents a 47.46% decrease in Dambkowski Carl's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 12, 2026 at 4:36 PM ET, 1 day after the trade was made.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.